fusion of PBSC and the i. 
Nowadays, long-lasting vascular devices are a cornerstone All patients in whom a double lumen high-flow catheter in the therapeutic management of cancer patients. 12 In partiwas installed for a PBSCT between November 1992 and cular, PBSCT requires a high-flow catheter for adequate June 1994 were included. cell collection through apheresis; 13 this requirement is achieved by placing two catheters. Ideally these catheters IVTT structure and routine should stay in place for several weeks to permit the reinThe interdisciplinary team is made up of four trained nurses, a surgeon and two infectious diseases physicians.
Correspondence: Dr P Volkow, Infectious Diseases, Instituto Nacional de
The catheter was installed by the surgeon or a surgical resiCancerología, San Fernando #22, Col. Tlalpán, México DF CP 14010 Received 5 September 1996; accepted 30 June 1997 dent (supervised by the IVTT surgeon) using a modified Seldinger technique. The catheter was fixed by means of a Catheter removal stitch with polypropylene 0000 Dermalon (Ethicon, Somer-
The catheter was removed under any of the following cirville, NJ, USA) at the exit site. The Permacath has a Dacron cumstances: completed therapy, death, voluntary withfelt cuff; in these cases, a small tunnel (between 5 and 7 cm drawal, thrombosis, catheter infection not responding to long) was created, leaving the cuff inside. The Mahurkar antimicrobials, catheter-related sepsis in neutropenic catheter was exteriorized without a tunnel. After installation patients, catheter obstruction or severe pain related to cathof the catheter, chest roentgenograms were taken to assess eter presence. position. Installation was avoided in patients with platelet counts below 35 ϫ 10 3 /dl. Weekly care of the exit site, or Diagnostic criteria twice a week in neutropenic patients, was undertaken by the IVTT nurses using three alcohol and three iodine-povidone Neutropenia was defined as a count of Ͻ1000/mm 3 neutroswabs. Outpatients were assessed weekly by the IVTT.
phil. Both lumens were heparinized daily at home by the patient Catheter-related subclavian vein thrombosis was diagor a trained relative. The IVTT personnel obtained all blood nosed on the basis of edema, collateral circulation and pain samples required for laboratory examinations from the cathipsilateral to catheter location, demonstrated by contrast eter, either in hospital or as an outpatient. phlebography or scintillography. All catheters were evaluated from installation to removal.
Local infection was diagnosed on the basis of: (1) puruUpon registration, follow-up forms were completed for lent secretion, tenderness, induration and culture-positive each patient with the following data recorded: sex, age, specimens of the exit site in non-neutropenic patients; and diagnosis, site of installation, complications related to (2) local erythema, tenderness and culture-positive speciinstallation, date and reason for removal, complications mens of the exit site in neutropenic patients. related to catheter permanence, flow problems and pain durCatheter-related bacteremia was diagnosed on the basis ing PBSC collection (apheresis), the number of PBSCTs of at least three of the following criteria: (1) clinical signs carried out, harvest yield and percentage cell viability. In of bacteremia or a temperature greater than 38.3°C; (2) cases of obstruction or flow problems during apheresis, a positive blood cultures for the same organism isolated from change in patient position was undertaken. At removal, the the exit site (either drawn from any lumen or from periphcatheter tip was sent for culture. All causes of removal eral venipuncture); (3) cultures of the exit site specimen were recorded. and the catheter tip yielding the same organism; and (4) Pre-transplantation conditioning high-dose chemotherapy remission of symptoms after catheter removal. consisted of ICE (5) Peripheral blood stem cells (PBSC) were mobilized with Gram stain and culture of the exit site were performed using a subcutaneous fixed dose of 300 g of G-CSF a sterile cotton swab and inoculation into blood and Mac-(Filgrastrim; Hoffman La Roche, Basel, Switzerland) 11, 20 Conkey agars. on days Ϫ11 to Ϫ6, and harvested with a Fenwal 3000
Catheter tip culture was performed using the Maki et al 21 (Baxter Healthcare, Deerfield, IL, USA) continuous flow technique. Blood cultures were performed by inoculating cell separator on days Ϫ7, Ϫ6 and Ϫ5. We processed 7 10 ml of blood into 100 ml of soy-tripticaseine broth. All liters of blood at a flow rate of 50 ml/min. The PBSCs were isolates were identified by the standards of the US National collected in a closed system apheresis kit (Baxter Committee for Clinical Laboratory Standards. Healthcare) and stored without further manipulation at 4°C in a blood bank refrigerator. Chemotherapy was given on Statistical analysis days Ϫ4, Ϫ3 and Ϫ2. The first PBSC unit collected was re-infused on day 0 and the second and third units on day
Incidence rates of infectious complications and thromboses 1. Patients received the same dose of G-CSF from day 0 were determined and expressed in terms of 1000 catheteruntil the absolute neutrophil count reached more than days for each type of catheter and for the whole group. The 1.0 ϫ 10 9 /l. survival distribution related to complication-free device/ CD34 ϩ cells were estimated from an aliquot of 5-length of catheter permanence was calculated by the 10 ϫ 10 9 /l cells. 2 Readings were taken with a flow cytoKaplan-Meier method. Statistical differences among the meter (Coulter, Hialeah, FL, USA).
incidence rate of infectious and non-infectious compliWhen an infection of the exit site was suspected (because cations were calculated using the 2 test. of pain, erythema or secretion of the exit site) a Gram stain and culture were performed. If the patient developed fever, blood culture specimens were drawn from each lumen and Results at least one more by peripheral venipuncture. If local infection or catheter-related bacteremia occurred, the insertion A total of 60 catheters were installed in 56 patients. Three site was cleansed daily and treatment with parenteral antinever started the PBSCT and in a fourth patient, the cathbiotics was initiated. If no signs of infection were present eter was accidentally placed in the mediastinum and 48 h later we kept the catheter; otherwise it was removed removed. These four catheters were not included in the analysis. Fifty-six catheters were used in 53 patients that and the catheter tip sent for culture.
completed the PBSCT (28 Permacath and 28 Mahurkar).
Four catheters were removed due to complications: one thrombosis and three infections (one Candidemia and two Thirteen patients (23%) underwent more than one PBSCT. Eleven patients underwent two PBSCTs (19.6%) and two local infections). Eighteen catheters (32%) had flow problems during apheresis, relieved by postural changes in patients, three (3.6%). In nine patients the same catheter was used for two procedures, and in one patient it was used patients; only one had an obstruction that did not allow cell collection (this catheter was placed in the saphenous vein). for three PBSCTs.
All catheters were percutaneously placed; 53 subclavian, Twenty-four catheters (42.8%) caused pain during apheresis; 23 patients rated it as moderate; and in only one case one internal jugular and two saphenous. There were 23 women (41%) and 33 men (59%). The mean age was 37 was it rated as severe (this catheter was placed in the saphenous vein). years Ϯ s.d. (range 16-39 ). Diagnoses were as follows: non-Hodgkin lymphoma 15 (26.8%), breast cancer 10
The average mononuclear cell harvest was 6.35 10 8 /kg (6.53 10 8 /kg in 28 Permacaths and 6.15 10 8 /kg in 25 (17.9%), testicular germ cell tumors 11 (19.6%). Hodgkin disease seven (12.5%), sarcomas six (10.7%), uterine-cerviMahurkars in whom the mononuclear harvest was known). The average number of CD34 ϩ cells was 22.9% (34.19% cal carcinoma three (5.3%), and one lung cancer, multiple myeloma, acute myeloid leukemia and ovary tumor (1.7%
for 10 Permacaths and 17.6% for 21 Mahurkars). The average percentage of cells viable at the time of re-infusion was each). No differences were found between the Mahurkar and Permacath groups on the basis of sex, age or diagnosis.
66.8% (64% for 28 Permacaths and 72% for 24 Mahurkars). We surveyed a total of 3260 catheter/days (2227 days
(7-106). The complication-free survival curve
High-dose chemotherapy with bone marrow or PBSCT support may increase the chance of curing some solid tumors 4 distribution for both catheters is shown in Figure 1 . The overall incidence rate of infectious complications was and lymphomas. 6,10 Indeed, for some patients, it may become the standard form of treatment, requiring more than 2.1 ϫ 1000 catheter-days, 1.8 for Permacaths and 2.50 for Mahurkars (OR 1.41, 95% CI 0.25-7.43). For neutropenic one PBSCT. 3, 22 This requires long-lasting vascular access to provide all the requirements needed during the procedure periods it was 3.6 ϫ 1000 catheter-days as compared to 1.6 ϫ 1000 catheter-days during non-neutrophenic periods and i.v. support in the post-transplant period. The use of a single apheresis catheter as long-term indwelling vascular (OR 2.2, 95% CI 0.39-11.69). We detected three thrombotic episodes (5.4%), with an incidence rate of thrombosis access in patients undergoing PBSCT is attractive as it avoids the cost and hazards of multiple catheters. of 0.9 ϫ 1000 catheter-days (0.4 for Permacaths and 1.7 for Mahurkars (OR 0.27 95% CI 0.01-3.72).
We present an experience using two catheters for apheresis and i.v. support, cared for exclusively by a multidisciSeven infectious episodes were recorded (12.5%); five (9%) were local and two (3.6%) were bacteremias. The plinary IVTT. In this study the incidence rate of complications is in the range of most of the long-indwelling microorganisms isolated are listed in Table 1 . vascular devices used for cancer patients. 23, 24 The overall incidence rate of infectious complications is higher than observed with a single lumen in our previously published experience. 17 It is recognized that a double lumen catheter increases the risk of infectious complications when compared with a single lumen; this could explain the higher rate of infection with the same care protocol. There was no statistical difference in infectious complications between the two catheters. The rate of infectious complications was double during neutropenic periods compared with non-neutropenic periods, but again it did not reach statistical significance, possibly because the number of events studied is too small. Table 1 Microorganisms isolated from patients with Permacath (P) and Mahurkar (M) catheter-related infection
Microorganisms

Local Bacteremia infection
Coagulase-negative staphylococci M, M, P -Coagulase-positive staphylococci P -Pseudomonas sp. P - Staphylococcus sp., as has been described in most studies
